Well-informed patients who understand their illness and treatment options comply better with treatment and, consequently, respond better. If a person has researched their illness, engaged in discussion about it, and taken part in treatment choice, their confidence in their treatment and their commitment to it will be greater.
 

Information is great not only for the patient, but also for the people who make the medications; with an increase in requirement for and competitive use of post-approval observational data there is much more visibility of how many good patients you have and how many do not respond to treatment. Not every drug is good for every patient.  Helping the right drugs get to the right people improves the overall effectiveness of a drug.
 

The Internet has matured into a dynamic environment where people engage in debate and expect to have a voice. Some information is good, some is not, and people are getting better at identifying the sites which provide the best information.  They revisit these sites and remain loyal to them.

Pharmaceutical companies have an opportunity to use the internet to engage in debates with patients and provide high quality information supporting their products.  If they don't act on the opportunity, the debate may just happen without them.
 

Cisiv has years of experience in using new media to inform and educate in highly interactive user friendly formats. We develop multimedia solutions which present balanced information in simple language that patients appreciate.  Our web sites contain easy-to-use content, including updating, polling, blogging and user contribution features.

Technically savvy, industry experienced, we design and build the new media to communicate with your patients.